RESEARCH TRIANGLE PARK, N.C. — Sue Cole, a financial services executive from Greensboro, is the new chair of the North Carolina Biotechnology Center’s board of directors.
Cole has more than 30 years of experience in financial services. She replaces Robert Timmins, a retired biotechnology executive, who led the board from 2002-2006.
“I’m honored to serve as chairwoman of this organization because biotechnology is extremely important to North Carolina’s economy and quality of life,” Cole said. “Biotechnology integrates many of our state’s treasured assets, including our university system, community colleges and entrepreneurial spirit. The Biotechnology Center, with its five regional offices now in place, is well positioned to leverage these assets for job creation and economic growth in all parts of the state.”
Cole is a principal with Granville Capital, Inc. Before joining Granville she was regional chief executive officer for the Mid-Atlantic region with U.S. Trust Company.
Cole also is a former chair of the North Carolina Citizens for Business and Industry. She remains a director with the organization.
N.C. Biotech Center: www.ncbiotech.org
